Huntington’s Disease and Swallowing: Managing Chorea-Related Aspiration Risk

Huntington’s disease (HD) is an autosomal dominant, progressive neurodegenerative disease caused by CAG trinucleotide repeat expansion in the HTT gene on chromosome 4. It produces a characteristic triad of motor symptoms (chorea, dystonia, and later rigidity), cognitive decline, and psychiatric manifestations. Dysphagia is present in the majority of patients with HD and is a leading cause of the aspiration pneumonia that is the most common cause of death in advanced disease.

This article follows ASHA Practice Portal guidance on adult dysphagia and NICE CG162.


Pathophysiology: How Chorea Disrupts Swallowing

The swallowing disorder in HD is driven primarily by chorea — involuntary, rapid, jerky movements that interrupt the voluntary motor sequence of swallowing at unpredictable moments. Unlike the hypokinetic dysarthria-dysphagia of Parkinson’s disease (where movements are slow and reduced), HD produces movements that are excessive, irregular and timed incorrectly.

The consequences for swallowing:

In advanced HD, as chorea is replaced by rigidity and bradykinesia (a characteristic disease trajectory in late stages), the swallowing disorder transitions toward a hypokinetic pattern more similar to Parkinson’s disease.


Nutritional Challenges: Hypermetabolism

HD is associated with involuntary hypermetabolism — the continuous choreic movements burn substantially more energy than normal resting metabolism. Patients with HD commonly require 1.5–2 times the normal caloric intake to maintain weight despite potentially normal or increased appetite. When dysphagia reduces intake, weight loss accelerates rapidly and the resultant sarcopenia further worsens swallowing function.

Maintaining adequate nutrition in HD dysphagia is therefore an active and challenging management goal. Routine weight monitoring (at least monthly), dietitian review, and caloric fortification of IDDSI-modified diets are all essential components of HD care.


Assessment

Timing and Disease Stage

SLT assessment should be conducted at a typical time of day when the patient’s chorea is at a representative level — not during a medication “on” peak (when chorea may be suppressed by medication adjustments) or during a period of extreme agitation (when testing is unreliable). For patients on tetrabenazine or deutetrabenazine (chorea-suppressing medications), assessment timing relative to medication should be documented.

Communication Challenges

Cognitive impairment and dysarthria in HD can make obtaining reliable self-report difficult. Caregiver informants are often essential. As disease progresses, the patient may have impaired insight into their own aspiration risk — a factor that must be considered in shared decision-making about dietary modification.

Instrumental Assessment

FEES is often appropriate because it can be adapted to a seated position and does not require the patient to be still on a radiology table for VFSS. However, choreic tongue movements can make it difficult to see the hypopharynx clearly on FEES — the SLT may need multiple observation periods to capture a representative picture of swallowing safety.

Prof. Karen Chan’s HKU Swallowing Research Lab has highlighted the need for condition-specific assessment protocols in HD that account for movement disorder variables not present in standard dysphagia assessment protocols.


Management

IDDSI Modification

The IDDSI framework guides dietary modification. Early in HD, the priority may be managing impulsive eating pace and bolus overfilling rather than textures. Later, as oral phase coordination deteriorates, IDDSI Level 5 (Minced & Moist) or Level 4 (Puréed) will be needed for solid foods.

Liquid modification is indicated when VFSS or FEES demonstrates aspiration of thin liquids. IDDSI Level 2 (Mildly Thick) is commonly the initial step; Level 3 (Moderately Thick) if needed.

A critical practical challenge: HD patients with hypermetabolism need high-calorie, high-protein modified diets. Standard IDDSI puréed or mashed hospital diets often fail to meet these requirements. Caloric fortification with cream, butter, protein supplements, and full-fat dairy is essential, in liaison with a specialist dietitian.

Managing Eating Pace

Medication Review

Some medications used in HD can worsen dysphagia:

Enteral Feeding Planning

As HD advances, oral feeding eventually becomes unsafe despite all management interventions. Anticipatory discussion about enteral feeding (PEG tube) should be initiated early — when the patient still has decision-making capacity — as part of advance care planning. HD-specific care guidelines recommend this discussion at diagnosis, rather than waiting for a feeding crisis.


When to Refer

Any HD patient with weight loss, recurrent chest infections, or mealtime duration exceeding 45 minutes should be referred to SLT and dietitian. See When to Refer to a Speech and Language Therapist.


References

  1. American Speech-Language-Hearing Association. Adult Dysphagia Practice Portal. https://www.asha.org/practice-portal/clinical-topics/adult-dysphagia/
  2. National Institute for Health and Care Excellence. Stroke Rehabilitation in Adults (CG162). https://www.nice.org.uk/guidance/cg162
  3. IDDSI. The IDDSI Framework. https://www.iddsi.org/framework
  4. Logemann JA, et al. (2015). Disorders of deglutition. Handbook of Clinical Neurology, 129, 465–487. PMID: 26315994